Home
:
Contact Us
About Us
Product Pipeline
Technology
Partnerships
Investors
Careers
Vision and Focus
Business Strategy
Management Team
Board of Directors
Directions
Inflammatory Arthritis
HIV/AIDS Vaccine
Congestive Heart Failure
Huntington's Disease
Technology Platform
About Gene Therapy
Partners
Manufacturing
Intellectual Property
Contact Us
Corporate Governance
Stock Information
Press Releases
Event Calendar
SEC Filings
Financial Reports
Analysts
Webcasts/Presentations
Contact Information
E-mail Alerts
Information Request
Benefit Summary
Jobs
Internships
Contact Us
TARGETED GENETICS CORPORATION
EVENTS
19-May-2008
Targeted Genetics at Rodman & Renshaw Annual Global Healthcare Conference
7-May-2008
Q1 2008 Targeted Genetics Earnings Conference Call
25-Mar-2008
Q4 2007 Targeted Genetics Earnings Conference Call
18-Mar-2008
Targeted Genetics at Washington Biotechnology & Biomedical Association Invest Northwest Conference
RECENT NEWS
7/10/2008
Targeted Genetics Corporation Recommended for up to $2.4 Million in Funding by Department of Defense
6/12/2008
Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
5/30/2008
Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
5/30/2008
Targeted Genetics Reports Additional Data From Inflammatory Arthritis Clinical Trial
5/29/2008
Targeted Genetics and University College London Participate in
5/8/2008
Targeted Genetics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Copyright 2006 Targeted Genetics Corporation.
Site Terms and Conditions